EndoBytes: Patient-Centered Approach to Hypercortisolism Screening and Care-Treatment and Long-Term Care of Patients with Hypercortisolism (Cushing Syndrome and MACS)

Treatment and Long-Term Care of Patients with Hypercortisolism (Cushing Syndrome and MACS)

Video Transcription

Video Summary

This module reviews treatment and long-term care for hypercortisolism, including Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS). Surgery is first-line for cortisol excess, but many require adjunctive therapies like steroidogenesis inhibitors, pituitary agents, or glucocorticoid receptor antagonists. Barriers include cost, side effects, and access disparities. Long-term care must address persistent cardiometabolic, bone, and quality-of-life issues via structured follow-up. A personalized, multimodal approach involving endocrinologists, surgeons, radiologists, and other specialists is crucial. Multidisciplinary teams at specialized centers improve outcomes, ensure comprehensive management, and optimize survivorship through integrated patient-centered care.

Meta Tag

Concept Hypercortisolism

Concept Cushing Syndrome

Concept Autonomous Cortisol Secretion

Concept Surgery

Concept Pharmacotherapy

Keywords

hypercortisolism treatment

Cushing Syndrome

Mild Autonomous Cortisol Secretion

steroidogenesis inhibitors

multidisciplinary care

Hypercortisolism

Cushing Syndrome

Autonomous Cortisol Secretion

Surgery

Pharmacotherapy


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274